Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Targeting TRPV1 for pain relief: limits, losers and laurels.

Szallasi A, Sheta M.

Expert Opin Investig Drugs. 2012 Sep;21(9):1351-69. doi: 10.1517/13543784.2012.704021. Epub 2012 Jul 11. Review.

PMID:
22780443
2.

Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Wong GY, Gavva NR.

Brain Res Rev. 2009 Apr;60(1):267-77. doi: 10.1016/j.brainresrev.2008.12.006. Epub 2008 Dec 25. Review.

PMID:
19150372
3.

Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?

Knotkova H, Pappagallo M, Szallasi A.

Clin J Pain. 2008 Feb;24(2):142-54. doi: 10.1097/AJP.0b013e318158ed9e. Review.

PMID:
18209521
4.

Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.

Szolcsányi J, Pintér E.

Expert Opin Ther Targets. 2013 Jun;17(6):641-57. doi: 10.1517/14728222.2013.772580. Epub 2013 Feb 20. Review.

PMID:
23421411
5.

Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.

Bölcskei K, Tékus V, Dézsi L, Szolcsányi J, Petho G.

Eur J Pain. 2010 May;14(5):480-6. doi: 10.1016/j.ejpain.2009.08.005. Epub 2009 Oct 1.

PMID:
19800272
6.

Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.

Gunthorpe MJ, Chizh BA.

Drug Discov Today. 2009 Jan;14(1-2):56-67. doi: 10.1016/j.drudis.2008.11.005. Epub 2008 Dec 26. Review.

PMID:
19063991
7.

Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials.

Kissin I, Szallasi A.

Curr Top Med Chem. 2011;11(17):2159-70. Review.

PMID:
21671878
8.

TRP channels and pain.

Cortright DN, Szallasi A.

Curr Pharm Des. 2009;15(15):1736-49. Review.

PMID:
19442187
9.

The functional regulation of TRPV1 and its role in pain sensitization.

Wang Y.

Neurochem Res. 2008 Oct;33(10):2008-12. doi: 10.1007/s11064-008-9750-5. Epub 2008 Jun 5. Review.

PMID:
18528757
10.

Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014).

Lee Y, Hong S, Cui M, Sharma PK, Lee J, Choi S.

Expert Opin Ther Pat. 2015 Mar;25(3):291-318. doi: 10.1517/13543776.2015.1008449. Review.

PMID:
25666693
11.

Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist.

Bates BD, Mitchell K, Keller JM, Chan CC, Swaim WD, Yaskovich R, Mannes AJ, Iadarola MJ.

Pain. 2010 Jun;149(3):522-8. doi: 10.1016/j.pain.2010.03.024. Epub 2010 Apr 18.

12.

Targeting TRP channels for pain relief.

Brederson JD, Kym PR, Szallasi A.

Eur J Pharmacol. 2013 Sep 15;716(1-3):61-76. doi: 10.1016/j.ejphar.2013.03.003. Epub 2013 Mar 14. Review.

PMID:
23500195
13.

Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature.

Voight EA, Kort ME.

Expert Opin Ther Pat. 2010 Sep;20(9):1107-22. doi: 10.1517/13543776.2010.497756. Review.

PMID:
20586701
14.

[Capsaicin receptor TRPV1].

Tominaga M.

Brain Nerve. 2008 May;60(5):493-501. Review. Japanese.

PMID:
18516971
15.

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

Gavva NR, Bannon AW, Hovland DN Jr, Lehto SG, Klionsky L, Surapaneni S, Immke DC, Henley C, Arik L, Bak A, Davis J, Ernst N, Hever G, Kuang R, Shi L, Tamir R, Wang J, Wang W, Zajic G, Zhu D, Norman MH, Louis JC, Magal E, Treanor JJ.

J Pharmacol Exp Ther. 2007 Oct;323(1):128-37. Epub 2007 Jul 25.

16.

Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.

García-Martínez C, Fernández-Carvajal A, Valenzuela B, Gomis A, Van Den Nest W, Ferroni S, Carreño C, Belmonte C, Ferrer-Montiel A.

J Pain. 2006 Oct;7(10):735-46.

PMID:
17018334
17.

Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief.

Jancsó G, Dux M, Oszlács O, Sántha P.

Br J Pharmacol. 2008 Dec;155(8):1139-41. doi: 10.1038/bjp.2008.375. Epub 2008 Nov 10.

18.

Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.

Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, de Novellis V, Di Marzo V.

J Neurosci. 2007 Dec 12;27(50):13739-49.

19.

TRPV1: a therapeutic target for novel analgesic drugs?

Szallasi A, Cruz F, Geppetti P.

Trends Mol Med. 2006 Nov;12(11):545-54. Epub 2006 Sep 25. Review.

PMID:
16996800
20.

Brain TRPV1: a depressing TR(i)P down memory lane?

Di Marzo V, Gobbi G, Szallasi A.

Trends Pharmacol Sci. 2008 Dec;29(12):594-600. doi: 10.1016/j.tips.2008.09.004. Epub 2008 Oct 22.

PMID:
18947889

Supplemental Content

Support Center